Key facts
- Ash’s last known valuation is $45.0M (Oct 2024).
- It has raised $19.6M across 1 recorded rounds; the latest was Later Stage VC (Series A) ($10.0M) in Oct 2024.
- Notable investors include Plug and Play Tech Center, 500 Global, Gaingels, Dorm Room Fund, AltaIR Capital — 24 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 24 names
- ·Watchlist + deal alerts for Ash
Funding rounds
1 roundsAbout Ash
Operator of a home health testing platform intended to offer at-home self-collected diagnostic testing services. The company integrates with clients so that they can offer at-home testing kits on behalf of patients to collect samples at home and send them back to partner labs, which are reviewed by licensed clinicians, enabling customers to access remote diagnostics with secure infrastructure or preferred tech stack.
- Industry
- Other Healthcare Services
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2019
- Employees
- 50
- Website
- poweredbyash.com/
- Ownership
- Privately Held (backing)
Ash doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ash shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ash in its N-PORT filings yet. We sweep new filings monthly.